Identifying Uncertain Tumor Locations in Skin Cancer Surgery
When Skin Cancer’s Location is a Mystery: How Surgeons Find the Answer
Uncertainty about the exact location of a skin cancer lesion can pose a challenge for surgeons, but a new study sheds light on how they navigate this issue.
researchers recently conducted a nationwide study to understand how frequently enough dermatologic surgeons encounter uncertain tumor sites and the strategies they use to pinpoint the location. The study, published in the September 2024 issue of Dermatology, analyzed data from 17,076 nonmelanoma skin cancer cases treated with Mohs micrographic surgery at 22 academic and private centers across the contry.
The focus was on cases where the lesion’s location was unclear, defined as a “lesion in question” (LIQ) with incomplete or uncertain site details.
Out of the 17,076 cases, only 98 (0.60%) presented with uncertain tumor sites. Interestingly, these cases were more common in older male patients and those who had undergone a biopsy more than 30 days prior to the surgery consultation.
To overcome this challenge, surgeons employed a variety of methods to confirm the site location. These included:
Re-checking documentation: 92% of surgeons revisited patient records.
Expanded physical exams: 91% conducted thorough physical examinations.
Patient guidance: 62% asked patients to use a mirror to help pinpoint the lesion.
Photographs: 15% requested photographs of the area.
Frozen section biopsies: 15% utilized frozen section biopsies for immediate analysis.
Consultation with referring physicians: 10% contacted the physician who initially diagnosed the lesion.
These efforts proved triumphant in 82% of cases, allowing surgeons to accurately identify the tumor site. Though, in 18% of cases, the procedure had to be postponed, primarily when the uncertain lesion was located in a non-facial area.
This study highlights the dedication of dermatologic surgeons to ensuring precise treatment for skin cancer, even when faced with the challenge of an uncertain lesion location. By employing a combination of investigative techniques, they strive to provide the best possible care for their patients.
When Skin Cancer’s Location is a Mystery: How Surgeons Find the Answer
uncertainty about the exact location of a skin cancer lesion can pose a challenge for surgeons, but a new study sheds light on how they navigate this issue.
Researchers recently conducted a nationwide study to understand how frequently dermatologic surgeons encounter uncertain tumor sites and the strategies they use to pinpoint the location. The study, published in the September 2024 issue of Dermatology, analyzed data from 17,076 nonmelanoma skin cancer cases treated with Mohs micrographic surgery at 22 academic and private centers across the country.
The focus was on cases where the lesion’s location was unclear, defined as a “lesion in question” (LIQ) with incomplete or uncertain site details. Out of the 17,076 cases, only 98 (0.60%) presented with uncertain tumor sites. Interestingly, these cases were more common in older male patients and those who had undergone a biopsy more than 30 days prior to the surgery consultation.
To overcome this challenge, surgeons employed a variety of methods to confirm the site location. These included:
Re-checking documentation: 92% of surgeons revisited patient records.
Expanded physical exams: 91% conducted thorough physical examinations.
Patient guidance: 62% asked patients to use a mirror to help pinpoint the lesion.
Photographs: 15% requested photographs of the area.
Frozen section biopsies: 15% utilized frozen section biopsies for immediate analysis.
Consultation with referring physicians: 10% contacted the physician who initially diagnosed the lesion.
These efforts proved triumphant in 82% of cases, allowing surgeons to accurately identify the tumor site. Though, in 18% of cases, the procedure had to be postponed, primarily when the uncertain lesion was located in a non-facial area.
This study highlights the dedication of dermatologic surgeons to ensuring precise treatment for skin cancer, even when faced with the challenge of an uncertain lesion location. By employing a combination of investigative techniques, they strive to provide the best possible care for their patients.